We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05147558
Brief Title: A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma

First Submitted : November 15, 2021
First Submitted that Met QC Criteria : December 6, 2021
First Posted : December 7, 2021

Last Update Submitted that Met QC Criteria : April 27, 2022
Last Update Posted : May 3, 2022